What does this research mean for the field?

Implementing an electronic health record alert for elevated FIB-4 increases provider documentation of liver fibrosis risk but does not significantly increase orders for confirmatory testing, indicating alerts alone are insufficient to change clinical practice. Novelty: ClaimNovelty.INCREMENTAL. Consensus alignment: ConsensusAlignment.NEUTRAL.

What question did this study set out to answer?

This project aims to evaluate whether EHR alerts for elevated FIB-4 can improve liver fibrosis screening in individuals with diabetes.

June 7, 2026Diabetes

2930-LB: Implementation of FIB-4 Alerts in EHRs to Increase Screening for Liver Disease

View Full Paper

Ask AI

Bookmark

Authors

SBSai Sumedha Bobba JNJeevan Nammi KCKristi Cohn

Discussion

Member takes

Overview

Randomized trial assesses EHR alerts improving liver fibrosis screening in individuals with T2D, indicating potential for enhanced patient care.

Key Points

This project aims to evaluate whether EHR alerts for elevated FIB-4 can improve liver fibrosis screening in individuals with diabetes.
Pre-intervention data gathered from new patients at a weight loss clinic (July-August 2025).
EHR alerts flagged patients with certain health metrics (BMI≥30 kg/m2, A1c≥5.7%, FIB-4≥1.3).
Post-intervention data collected from December 2025 to February 2026.
FIB-4 referenced in notes increased from 1.1% pre-intervention to 9% post-intervention (p=0.002).
50.5% of post-intervention patients had labs required to calculate FIB-4 within 1 year, up from pre-intervention.
No significant change in orders for ELF or elastography was observed.

Cite This Study

Bobba et al. (2026) studied this question.

synapsesocial.com/papers/6a250b0e7def13d035e1b165 https://doi.org/10.2337/db26-2930-lb

View Full Paper

Ask AI

Bookmark

June 7, 2026Diabetes

2930-LB: Implementation of FIB-4 Alerts in EHRs to Increase Screening for Liver Disease

View Full Paper

Ask AI

Bookmark

Authors

SBSai Sumedha Bobba JNJeevan Nammi KCKristi Cohn

Discussion

Member takes

Overview

Randomized trial assesses EHR alerts improving liver fibrosis screening in individuals with T2D, indicating potential for enhanced patient care.

Key Points

This project aims to evaluate whether EHR alerts for elevated FIB-4 can improve liver fibrosis screening in individuals with diabetes.
Pre-intervention data gathered from new patients at a weight loss clinic (July-August 2025).
EHR alerts flagged patients with certain health metrics (BMI≥30 kg/m2, A1c≥5.7%, FIB-4≥1.3).
Post-intervention data collected from December 2025 to February 2026.
FIB-4 referenced in notes increased from 1.1% pre-intervention to 9% post-intervention (p=0.002).
50.5% of post-intervention patients had labs required to calculate FIB-4 within 1 year, up from pre-intervention.
No significant change in orders for ELF or elastography was observed.

Cite This Study

Bobba et al. (2026) studied this question.

synapsesocial.com/papers/6a250b0e7def13d035e1b165 https://doi.org/10.2337/db26-2930-lb

View Full Paper

Ask AI

Bookmark